Scope of this article
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
This translation is provided for general access and has no recorded medical-language review.
Editorial general information — not a clinical-review record
Published: Updated: Publisher: Dr. Murat Toktamışoğlu
Reducing discomfort during HIFU is not the same as completely suppressing anatomically unexpected, sharp or electric pain. Anaesthesia should be planned around area, device, dose, health history and monitoring; absence of pain must not become permission to use more energy.
This translation has no recorded clinical or medical-language review.
Studies report average pain scores, but device, transducer, area, energy and measurement time vary. Brief heat or prickling may occur, yet an electrical shock sensation, unilateral radiating pain, a visual symptom or weakness should not automatically be called normal. Predetermined stop criteria are more useful than treating a low pain number as the goal of the procedure.
For a topical product, document its name, amount, surface area, contact time and skin integrity. Excessive use across a wide or occluded area may increase systemic absorption. If injection, nerve block or sedation is considered, medicines, allergies, respiratory and circulatory monitoring, escort requirements and emergency readiness need separate planning. These methods are not evidence that device-related risk has been reduced.
Before treatment, explain which sensations require an immediate report. A new, intense or anatomically suspicious symptom should prompt a stop and reassessment, not merely a lower setting. Suppressed pain does not show that the target is safe. Record anaesthetic, dose and time together with HIFU parameters and events. A persistent neurological symptom warrants prompt medical evaluation rather than routine reassurance.
This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.
These links are editorial starting points used to examine the article's boundaries.
Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Ling J, Zhao H · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Riopelle AM, Geisler AN, Eber A, Dover JS · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Niu Z et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Systematic review authors; Aesthetic Surgery Journal · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review